ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial

Paulien G. de Jong, Siobhan Quenby, Kitty W. M. Bloemenkamp, Babette A. M. Braams-Lisman, Jan Peter de Bruin, Arri Coomarasamy, Michele David, Maria T. DeSancho, Olivier W. H. van der Heijden, Annemieke Hoek, Barbara A. Hutten, Kristin Jochmans, Carolien A. M. Koks, Walter K. H. Kuchenbecker, Ben Willem J. Mol, Helen L. Torrance, Hubertina C. J. Scheepers, Mary D. Stephenson, Harold R. Verhoeve, Jantien VisserJohanna I. P. de Vries, Mariette Goddijn, Saskia Middeldorp

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number208
JournalTrials
Volume16
DOIs
Publication statusPublished - 7 May 2015

Keywords

  • Recurrent miscarriage
  • Pregnancy complications
  • Fetal death
  • Thrombophilia
  • Anticoagulants
  • Aspirin
  • Low-molecular-weight-heparin

Cite this